| Secondary |
| Product Used For Unknown Indication |
28.5% |
| Pain |
16.1% |
| Drug Use For Unknown Indication |
10.3% |
| Hypertension |
7.9% |
| Rheumatoid Arthritis |
6.2% |
| Restless Legs Syndrome |
4.1% |
| Neuralgia |
3.3% |
| Osteoarthritis |
2.9% |
| Cardiac Failure |
2.5% |
| Constipation |
2.5% |
| Acute Lymphocytic Leukaemia |
2.1% |
| Sleep Disorder |
2.1% |
| Breast Cancer Metastatic |
1.7% |
| Gastric Disorder |
1.7% |
| Hypothyroidism |
1.7% |
| Metastatic Gastric Cancer |
1.7% |
| Benign Prostatic Hyperplasia |
1.2% |
| Depression |
1.2% |
| Diabetes Mellitus |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
|
| Procedural Haemorrhage |
16.7% |
| Suicide Attempt |
11.9% |
| Somnolence |
7.1% |
| Vomiting |
7.1% |
| Agitation |
4.8% |
| Malignant Neoplasm Of Pleura |
4.8% |
| Mixed Liver Injury |
4.8% |
| Plasmacytoma |
4.8% |
| Respiratory Tract Oedema |
4.8% |
| Retrograde Ejaculation |
4.8% |
| Sopor |
4.8% |
| Weight Decreased |
4.8% |
| Aggression |
2.4% |
| Cauda Equina Syndrome |
2.4% |
| Dehydration |
2.4% |
| Drug Interaction |
2.4% |
| Dyspnoea |
2.4% |
| Erectile Dysfunction |
2.4% |
| Gastroenteritis |
2.4% |
| Hallucination |
2.4% |
|
| Concomitant |
| Pain |
21.8% |
| Product Used For Unknown Indication |
18.2% |
| Prophylaxis |
8.3% |
| Hypertension |
6.5% |
| Rheumatoid Arthritis |
5.0% |
| Non-small Cell Lung Cancer |
4.9% |
| Constipation |
4.5% |
| Asthma |
3.8% |
| Tumour Pain |
3.6% |
| Depression |
3.3% |
| Osteoporosis |
3.1% |
| Nausea |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Metastases To Bone |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Back Pain |
1.8% |
| Insomnia |
1.7% |
| Post Herpetic Neuralgia |
1.5% |
| Rotator Cuff Syndrome |
1.5% |
| Viral Infection |
1.5% |
|
| General Physical Health Deterioration |
7.3% |
| Vomiting |
7.3% |
| Hyperkalaemia |
6.4% |
| Nausea |
6.4% |
| Pain |
6.4% |
| Respiratory Failure |
6.4% |
| Weight Decreased |
6.4% |
| Gastrointestinal Haemorrhage |
5.5% |
| Pyrexia |
5.5% |
| Thrombocytopenia |
5.5% |
| Atrial Fibrillation |
4.5% |
| Pneumonia |
4.5% |
| Cardiac Failure |
3.6% |
| Dyspnoea |
3.6% |
| Hyponatraemia |
3.6% |
| Pulmonary Embolism |
3.6% |
| Urinary Tract Infection |
3.6% |
| Weight Increased |
3.6% |
| Wrong Technique In Drug Usage Process |
3.6% |
| Cerebrovascular Accident |
2.7% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
24.7% |
| Pain |
13.7% |
| Diabetes Mellitus |
11.0% |
| Benign Prostatic Hyperplasia |
6.8% |
| Hypertension |
6.8% |
| Insomnia |
5.5% |
| Restlessness |
4.1% |
| Atrial Fibrillation |
2.7% |
| Back Pain |
2.7% |
| Cardiac Failure |
2.7% |
| Essential Hypertension |
2.7% |
| Peripheral Arterial Occlusive Disease |
2.7% |
| Prophylactic Chemotherapy |
2.7% |
| Sleep Disorder |
2.7% |
| Arteriosclerosis |
1.4% |
| Atrial Flutter |
1.4% |
| Cardiac Flutter |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Hyperlipidaemia |
1.4% |
| Ischaemic Heart Disease Prophylaxis |
1.4% |
|
| Weight Decreased |
61.5% |
| Hypoglycaemia |
15.4% |
| Pain |
15.4% |
| Drug Interaction |
7.7% |
|
